Daunoxome in the treatment of relapsed/refractory low grade and intermediate grade non-Hodgkin's lymphoma (NHL)

被引：0
|
作者：
Tulpule, A
Rarick, MU
Kolitz, J
Bernstein, J
HarveyBuchanan, L
Espina, BM
Trader, G
Mukwaya, G
Onetto, N
Gill, PS
Levine, AM
机构：
[1] UNIV SO CALIF,SCH MED,LOS ANGELES,CA 90089
[2] NW KAISER PERMANENTE,PORTLAND,OR
[3] N SHORE UNIV HOSP,MANHASSET,NY
[4] SCRIPPS CLIN & HOSP,LA JOLLA,CA
[5] NEXSTAR PHARMACEUT,BOULDER,CO
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：846 / 846
页数：1
相关论文
共 50 条
  • [1] Liposomal daunorubicin (Daunoxome®) is active in the treatment of relapsed/refractory low grade and intermediate grade non-Hodgkin's lymphoma
    Tulpule, A
    Rarick, MU
    Kolitz, J
    Myers, A
    Bernstein, J
    Harvey-Buchanan, L
    Espina, BM
    Ptaszynski, M
    Mukwaya, G
    Levine, AM
    BLOOD, 1998, 92 (10) : 241B - 241B
  • [2] Liposomal encapsulated daunorubicin (DaunoXome(R)) has activity in relapsed/refractory low grade and intermediate grade non-Hodgkin's lymphoma (NHL).
    Tulpule, A
    Rarick, MU
    Kolitz, J
    Bernstein, J
    Traynor, A
    Myers, A
    HarveyBuchanan, L
    Salvosa, MVD
    Espina, BM
    Mukwaya, G
    Ross, M
    Levine, AM
    BLOOD, 1996, 88 (10) : 358 - 358
  • [3] Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma
    Tulpule, A
    Schiller, G
    Harvey-Buchanan, LA
    Lee, M
    Espina, BM
    Khan, AU
    Boswell, W
    Nathwani, B
    Levine, AM
    CANCER, 1998, 83 (11) : 2370 - 2376
  • [4] Bendamustine, vincristine, prednisolone in relapsed and refractory low grade non-Hodgkin's lymphoma
    Kath, R
    Blumenstengel, K
    Fricke, HJ
    Peters, HD
    Höffken, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (08) : 198 - 202
  • [5] Gemcitabine as a single agent in the treatment of relapsed or refractory low-grade non-Hodgkin's lymphoma
    Dumontet, C
    Morschhauser, F
    Solal-Celigny, P
    Bouafia, F
    Bourgeois, E
    Thieblemont, C
    Leleu, X
    Hequet, O
    Salles, G
    Coiffier, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 113 (03) : 772 - 778
  • [6] Rituximab:: Sustained remissions in patients (pts) with relapsed or refractory low grade or follicular non-Hodgkin's lymphoma (LG/NHL).
    Grillo-López, AJ
    Shen, D
    Lee, D
    Dallaire, BK
    Dowden, S
    White, CA
    BLOOD, 2000, 96 (11) : 238B - 238B
  • [7] Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma
    Stein, RS
    Greer, JP
    Goodman, S
    Brandt, SJ
    Morgan, DS
    Macon, WR
    McCurley, TL
    Wolff, SN
    BONE MARROW TRANSPLANTATION, 2000, 25 (03) : 257 - 262
  • [8] Intensified preparative regimens and autologous transplantation in refractory or relapsed intermediate grade non-Hodgkin's lymphoma
    RS Stein
    JP Greer
    S Goodman
    SJ Brandt
    DS Morgan
    WR Macon
    TL McCurley
    SN Wolff
    Bone Marrow Transplantation, 2000, 25 : 257 - 262
  • [9] Treatment of intermediate-grade and high-grade non-Hodgkin's lymphoma
    Wirth, A
    Prince, HM
    Wolf, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (20): : 1475 - 1475
  • [10] Fludarabine, mitoxantrone and dexametasone in the treatment of relapsed and refractory low-grade non-Hodgkin lymphoma.
    Sawczuk-Chabin, J
    Kalinka, E
    Centkowski, P
    Budziszewska, K
    Ceglarek, B
    Najda, J
    Blasinska-Morawiec, M
    Sulek, K
    Holowiecki, J
    Konopka, L
    Warzocha, K
    BLOOD, 2005, 106 (11) : 265B - 265B
12345